X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10704) 10704
Book Review (2283) 2283
Publication (605) 605
Newsletter (492) 492
Newspaper Article (286) 286
Book Chapter (80) 80
Conference Proceeding (67) 67
Magazine Article (30) 30
Book / eBook (27) 27
Dissertation (11) 11
Trade Publication Article (9) 9
Reference (4) 4
Web Resource (3) 3
Data Set (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8828) 8828
humans (8218) 8218
male (4975) 4975
female (4795) 4795
gastroesophageal reflux (4525) 4525
middle aged (3920) 3920
gastroenterology & hepatology (3367) 3367
adult (3347) 3347
surgery (3095) 3095
aged (2899) 2899
abridged index medicus (2028) 2028
gastroesophageal reflux - physiopathology (1624) 1624
gastroesophageal reflux - surgery (1578) 1578
medicine & public health (1545) 1545
adenocarcinoma (1485) 1485
gastroesophageal junction (1463) 1463
treatment outcome (1448) 1448
oncology (1423) 1423
gastroesophageal reflux disease (1421) 1421
gastroesophageal-reflux disease (1348) 1348
esophagus (1340) 1340
cancer (1332) 1332
manometry (1256) 1256
gastroenterology (1184) 1184
gastroesophageal reflux - diagnosis (1183) 1183
gastroesophageal reflux - complications (1138) 1138
esophagogastric junction (1090) 1090
esophagogastric junction - physiopathology (1064) 1064
care and treatment (1036) 1036
hydrogen-ion concentration (1007) 1007
endoscopy (994) 994
aged, 80 and over (990) 990
risk factors (956) 956
follow-up studies (927) 927
retrospective studies (906) 906
gastroesophageal reflux - etiology (880) 880
prospective studies (877) 877
barretts-esophagus (869) 869
diagnosis (855) 855
laparoscopy (842) 842
esophageal cancer (838) 838
disease (836) 836
pressure (831) 831
adolescent (826) 826
research (820) 820
esophageal neoplasms - pathology (807) 807
gastroesophageal-reflux (807) 807
analysis (803) 803
prevalence (795) 795
animals (793) 793
barrett's esophagus (769) 769
fundoplication (750) 750
lower esophageal sphincter (677) 677
chemotherapy (659) 659
gerd (656) 656
fundoplication - methods (649) 649
hepatology (632) 632
adenocarcinoma - pathology (629) 629
prognosis (624) 624
medical research (611) 611
esophagoscopy (607) 607
health aspects (604) 604
barrett esophagus - pathology (603) 603
esophagus - pathology (586) 586
gastroesophageal reflux - pathology (583) 583
obesity (581) 581
gastroenterology and hepatology (572) 572
child (556) 556
gastroesophageal reflux - drug therapy (553) 553
esophagogastric junction - pathology (544) 544
symptoms (543) 543
esophagitis (542) 542
medicine, experimental (531) 531
abdominal surgery (529) 529
antireflux surgery (520) 520
stomach neoplasms - pathology (516) 516
esophagus - physiopathology (512) 512
esophagogastric junction - surgery (510) 510
time factors (508) 508
gastric cancer (506) 506
biopsy (498) 498
carcinoma (493) 493
dysphagia (493) 493
infant (490) 490
proton pump inhibitors (487) 487
young adult (479) 479
therapy (477) 477
intestinal metaplasia (467) 467
management (466) 466
gastric cardia (458) 458
hernia (455) 455
nissen fundoplication (455) 455
esophageal neoplasms - surgery (452) 452
gastroesophageal reflux - therapy (452) 452
stomach cancer (439) 439
pediatrics (437) 437
laparoscopy - methods (424) 424
patients (421) 421
neoplasm staging (413) 413
stomach (407) 407
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10962) 10962
German (207) 207
Spanish (112) 112
French (101) 101
Italian (55) 55
Korean (46) 46
Russian (45) 45
Japanese (32) 32
Portuguese (22) 22
Chinese (18) 18
Polish (10) 10
Czech (6) 6
Dutch (5) 5
Finnish (5) 5
Hungarian (4) 4
Romanian (4) 4
Bulgarian (2) 2
Croatian (2) 2
Ukrainian (2) 2
Danish (1) 1
Norwegian (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 02/2015, Volume 13, Issue 2, pp. 194 - 227
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2015, Volume 137, Issue 3, pp. 678 - 685
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 81, pp. 183 - 190
Journal Article
Nature, ISSN 0028-0836, 10/2017, Volume 550, Issue 7677, pp. 529 - 533
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 13, pp. 2823 - 2831
Abstract Background Patients with advanced adenocarcinoma of the gastroesophageal junction/stomach are treated by combination chemotherapy, with minimal... 
Hematology, Oncology and Palliative Medicine | Adenocarcinoma | KRAS | Gastroesophageal junction | Drug therapy | SURVIVAL | II TRIAL | FOLINIC ACID | FLUOROURACIL | CANCER | GROWTH-FACTOR RECEPTOR | OVEREXPRESSION | AMPLIFICATION | ONCOLOGY | EXPRESSION | HER3 | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | United States | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Esophageal Neoplasms - pathology | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Adenocarcinoma - genetics | Cetuximab | Stomach Neoplasms - genetics | Drug Administration Schedule | Kaplan-Meier Estimate | Esophagogastric Junction - pathology | Proto-Oncogene Proteins - genetics | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Taxoids - administration & dosage | Esophageal Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Care and treatment | Metastasis | Analysis | Index Medicus
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2011, Volume 11, Issue 1, pp. 266 - 266
Background: 18-Fluorodeoxyglucose-PET (F-18-FDG-PET) can be used for early response assessment in patients with locally advanced adenocarcinomas of the... 
SURVIVAL | SURGERY | ESOPHAGEAL-CARCINOMA | PHASE-II TRIAL | GASTROESOPHAGEAL JUNCTION | CISPLATIN | ONCOLOGY | GASTRIC-CARCINOMA | DOCETAXEL | Adenocarcinoma - pathology | Prospective Studies | Capecitabine | Humans | Salvage Therapy | Antineoplastic Agents - therapeutic use | Esophageal Neoplasms - radiotherapy | Positron-Emission Tomography | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Patient Selection | Esophagogastric Junction - diagnostic imaging | Multicenter Studies as Topic - methods | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Esophageal Neoplasms - surgery | Neoadjuvant Therapy | Radiopharmaceuticals | Adenocarcinoma - radiotherapy | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Esophagectomy | Treatment Outcome | Combined Modality Therapy | Adenocarcinoma - drug therapy | Taxoids - administration & dosage | Fluorodeoxyglucose F18 | Adenocarcinoma - diagnostic imaging | Clinical Trials as Topic - methods | Fluorine Radioisotopes | Esophageal Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Esophageal Neoplasms - diagnostic imaging | Germany | Adenocarcinoma - surgery | Care and treatment | Usage | PET imaging | Adjuvant treatment | Diagnosis | Research | Health aspects | Esophageal cancer | Cancer | Index Medicus
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 09/2014, Volume 1325, Issue 1, pp. 197 - 210
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2014, Volume 73, Issue 4, pp. 737 - 747
The aim of this study was to characterize trastuzumab population pharmacokinetics (PKs) in patients with human epidermal growth factor receptor 2-positive... 
Population pharmacokinetics | Gastroesophageal junction cancer | Medicine & Public Health | Exposure–response | Oncology | Cancer Research | Pharmacology/Toxicology | Gastric cancer | Trastuzumab | Exposure-response | SURVIVAL | NEU ONCOGENE | EGF | RECEPTOR | HER-2 | THERAPEUTIC MONOCLONAL-ANTIBODIES | BREAST-CANCER | AMPLIFICATION | GENE | ONCOLOGY | PHARMACOLOGY & PHARMACY | rastuzumab | Receptor, ErbB-2 - genetics | Capecitabine | Esophageal Neoplasms - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Antibodies, Monoclonal, Humanized - blood | Esophageal Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Esophagogastric Junction - metabolism | Esophagogastric Junction - pathology | Stomach Neoplasms - drug therapy | Stomach Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Epidermal growth factor | Analysis | Antineoplastic agents | Cancer | Index Medicus
Journal Article